YaoGeJu

Company directoryChina company filings

Jiangsu TaslyDiYi Pharmaceutical Co., Ltd

As of 20 November 2026, for the company name Jiangsu TaslyDiYi Pharmaceutical Co., Ltd as recorded, 12 applications with this name as first applicant are listed as under review at China's CDE; the CDE acceptance records name it as first applicant on 41 records, across 28 drug names; since 24 August 2026, the records list No longer listed under review: 1 application; the chemical-drug catalogue lists 28 active records with this name as holder; 31 active API registrations list this name as first registered company; 4 further acceptance records name it after the first applicant.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/20
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/20.

Drug filings

41 acceptance records as first applicant, grouped into 28 source drug names. Source data as of 2026/11/20.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Sevelamer Carbonate Tablets 2 records · Latest accepted 2026/07/06

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601599Generic2026/07/06Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
CYHS2401359Generic2024/05/08Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Propranolol hydrochloride oral solution 1 records · Latest accepted 2026/06/18

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601449Generic2026/06/18Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Ambroxol Hydrochloride Drops 1 records · Latest accepted 2026/06/18

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601448Generic2026/06/18Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Teneligliptin Hydrobromide Hydrate Tablets 1 records · Latest accepted 2025/12/10

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2504230Generic2025/12/10Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
JS1-1-01片 · No verified English name 1 records · Latest accepted 2025/12/03

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHB2500320Supplement2025/12/03Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) 1 records · Latest accepted 2025/09/16

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503405Generic2025/09/16Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
达格列净二甲双胍缓释片(II) · No verified English name 1 records · Latest accepted 2025/09/16

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503406Generic2025/09/16Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets(III) 1 records · Latest accepted 2025/09/16

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503407Generic2025/09/16Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Azilsartan Medoxomil Potassium Tablets 2 records · Latest accepted 2025/08/08

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502864Generic2025/08/08Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
CYHS2502863Generic2025/08/08Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
TSL2109胶囊 · No verified English name 2 records · Latest accepted 2025/07/24

New drug · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2500754New drug2025/07/24Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Zhongguo Yao Ke University romanizedCDE ↗
CXHL2500753New drug2025/07/24Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Zhongguo Yao Ke University romanizedCDE ↗
盐酸西替利嗪滴剂 · No verified English name 1 records · Latest accepted 2025/06/26

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502279Generic2025/06/26Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
地氯雷他定口服溶液 · No verified English name 2 records · Latest accepted 2025/05/22

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2501850Generic2025/05/22Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
CYHS2501849Generic2025/05/22Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
PXT3003 · No verified English name 1 records · Latest accepted 2025/04/11

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHS2500027New drug2025/04/11Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Raltitrexed for Injection 1 records · Latest accepted 2025/01/08

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500130Generic2025/01/08Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
波生坦分散片 · No verified English name 1 records · Latest accepted 2024/12/24

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2404493Generic2024/12/24Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Vonoprazan Fumarate Tablets 2 records · Latest accepted 2024/09/30

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403322Generic2024/09/30Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
CYHS2403321Generic2024/09/30Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Minoxidil Liniment 2 records · Latest accepted 2024/04/26

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2401276Generic2024/04/26Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Henan Tian Di Pharma Co., Ltd. romanizedCDE ↗
CYHS2401275Generic2024/04/26Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Henan Tian Di Pharma Co., Ltd. romanizedCDE ↗
Torsemide Injection 2 records · Latest accepted 2023/10/24

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302873Generic2023/10/24Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Chengdu Shi Hai Tong Pharma Co., Ltd. romanizedCDE ↗
CYHS2302872Generic2023/10/24Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Chengdu Shi Hai Tong Pharma Co., Ltd. romanizedCDE ↗
Rivaroxaban Tablets 4 records · Latest accepted 2023/10/11

Supplement · 1Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2302243Supplement2023/10/11Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
CYHS2200137Generic2022/01/20Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
CYHS2200136Generic2022/01/20Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
CYHS2200135Generic2022/01/20Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Ketotifen Fumarate Tablets 1 records · Latest accepted 2023/07/12

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350557Supplement2023/07/12Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Nicorandil Tablets 1 records · Latest accepted 2023/06/12

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2350487Supplement2023/06/12Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Dapoxetine Hydrochloride Tablets 2 records · Latest accepted 2023/05/16

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301320Generic2023/05/16Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
CYHS2301319Generic2023/05/16Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Baclofen Oral Solution 1 records · Latest accepted 2023/04/18

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301070Generic2023/04/18Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
Perampanel Tablets 2 records · Latest accepted 2022/08/31

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201422Generic2022/08/31Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
CYHS2201421Generic2022/08/31Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
Procaterol Hydrochloride Oral Solution 1 records · Latest accepted 2022/07/15

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201079Generic2022/07/15Jiangsu TaslyDiYi Pharmaceutical Co., Ltd; Nanjing Hai Na Pharmaceutical Co., Ltd. romanizedCDE ↗
Lisinopril and Hydrochlorothiazide Tablets 1 records · Latest accepted 2021/08/05

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150780Supplement2021/08/05Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Tadalafil Tablets 2 records · Latest accepted 2021/03/25

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2101049Supplement2021/03/25Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
CYHB2100105Supplement2021/01/19Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Bortezomib For Injection 1 records · Latest accepted 2021/02/02

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2100144Generic2021/02/02Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗

Changes in the last 90 days

1 events from 2026/08/24 to 2026/11/21. CDE data as of 2026/11/20; NMPA data as of 2026/11/20.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

No longer listed under review: 1 application

  1. 2026/11/20No longer listed under review

    PXT3003 · No verified English name

    CXHS2500027

    Fact date: 2026/11/20 · Date added to this site: 2026/11/20

    Accepted: 2025/04/11

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗

Under review

12 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/20.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Sevelamer Carbonate Tablets CYHS2601599Generic2026/07/06Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Propranolol hydrochloride oral solution CYHS2601449Generic2026/06/18Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Ambroxol Hydrochloride Drops CYHS2601448Generic2026/06/18Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Teneligliptin Hydrobromide Hydrate Tablets CYHS2504230Generic2025/12/10Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets(III) CYHS2503407Generic2025/09/16Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
达格列净二甲双胍缓释片(II) · No verified English name CYHS2503406Generic2025/09/16Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) CYHS2503405Generic2025/09/16Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Azilsartan Medoxomil Potassium Tablets CYHS2502864Generic2025/08/08Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Azilsartan Medoxomil Potassium Tablets CYHS2502863Generic2025/08/08Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
盐酸西替利嗪滴剂 · No verified English name CYHS2502279Generic2025/06/26Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
地氯雷他定口服溶液 · No verified English name CYHS2501850Generic2025/05/22Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
地氯雷他定口服溶液 · No verified English name CYHS2501849Generic2025/05/22Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗

Catalogue holder records

28 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/20. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerNMPA approval no.ApprovedCatalogue category (source text)View source
波生坦分散片 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202646882026/06/10Generic approved under the new chemical-drug registration classificationCDE ↗
Vonoprazan Fumarate TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202644082026/05/19Generic approved under the new chemical-drug registration classificationCDE ↗
Vonoprazan Fumarate TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202644092026/05/19Generic approved under the new chemical-drug registration classificationCDE ↗
Torsemide InjectionJiangsu TaslyDiYi Pharmaceutical Co., LtdChengdu Shi Hai Tong Pharma Co., Ltd. romanized国药准字H202542262025/05/20Not stated by sourceCDE ↗
Torsemide InjectionJiangsu TaslyDiYi Pharmaceutical Co., LtdChengdu Shi Hai Tong Pharma Co., Ltd. romanized国药准字H202542252025/05/20Generic approved under the new chemical-drug registration classificationCDE ↗
Rivaroxaban TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202471832024/08/05Generic approved under the new chemical-drug registration classificationCDE ↗
Dapoxetine Hydrochloride TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202443582024/06/28Generic approved under the new chemical-drug registration classificationCDE ↗
Dapoxetine Hydrochloride TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202443592024/06/28Generic approved under the new chemical-drug registration classificationCDE ↗
Ketotifen Fumarate TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H320236602024/06/14Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Nicorandil TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H320256562024/03/22Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Rivaroxaban TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202339992023/08/01Not stated by sourceCDE ↗
Rivaroxaban TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202340002023/08/01Generic approved under the new chemical-drug registration classificationCDE ↗
Bortezomib For InjectionJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202236312022/08/30Generic approved under the new chemical-drug registration classificationCDE ↗
Lisinopril and Hydrochlorothiazide TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H200800802022/08/23Not stated by sourceCDE ↗
Memantine Hydrochloride Sustained-release CapsulesJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202139392021/12/14Generic approved under the new chemical-drug registration classificationCDE ↗
Memantine Hydrochloride Sustained-release CapsulesJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202139382021/12/14Generic approved under the new chemical-drug registration classificationCDE ↗
Tadalafil TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202171232021/11/22Generic approved under the new chemical-drug registration classificationCDE ↗
Temozolomide For InjectionJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202137932021/10/19Generic approved under the new chemical-drug registration classificationCDE ↗
Bezafibrate Sustained Realease TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202137962021/10/19Generic approved under the new chemical-drug registration classificationCDE ↗
Tadalafil TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202170852021/10/10Other drugCDE ↗
Clozapine TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H320231252021/01/29Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Metformin Hydrochloride TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H320201972021/01/05Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Minodronic acid TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202037362020/12/29Generic approved under the new chemical-drug registration classificationCDE ↗
吉非替尼片 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H202037042020/12/25Generic approved under the new chemical-drug registration classificationCDE ↗
Captopril TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H320231242020/10/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Sulpiride TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H320231262020/07/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Trihexyphenidyl Hydrochloride TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H320231292020/04/20Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Tadalafil TabletsJiangsu TaslyDiYi Pharmaceutical Co., LtdJiangsu TaslyDiYi Pharmaceutical Co., Ltd国药准字H201934162019/12/26Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

31 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/20.

NameCompany / applicantRegistration numberStatusSource update dateView source
乌帕替尼 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20250001484I2026/02/14CDE ↗
利非司特 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20250001421I2025/12/23CDE ↗
氢溴酸替格列汀 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20250001275I2025/11/28CDE ↗
佐匹克隆 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20250000459A2026/10/16CDE ↗
酒石酸匹莫范色林 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20250000066I2025/02/07CDE ↗
枸橼酸伊沙佐米 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20250000103A2026/06/30CDE ↗
雷替曲塞 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20240001432A2026/08/04CDE ↗
波生坦 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20240001390A2026/05/21CDE ↗
富马酸伏诺拉生 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20240000817A2026/03/26CDE ↗
右佐匹克隆 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20230001009A2025/05/23CDE ↗
盐酸苯达莫司汀 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20230000544A2024/12/13CDE ↗
马来酸阿法替尼 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20210000923A2023/08/21CDE ↗
利伐沙班 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20210001082A2023/04/07CDE ↗
硼替佐米 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20200001372A2022/08/18CDE ↗
左舒必利 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190021489I2020/01/10CDE ↗
他达拉非 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190021561A2024/11/12CDE ↗
阿德福韦酯 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190008281A—CDE ↗
盐酸非索非那定 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190006077A2025/08/22CDE ↗
盐酸吡格列酮 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190005807A2025/06/21CDE ↗
苯扎贝特 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190003930A2025/06/05CDE ↗
西洛他唑 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190003352A2025/05/29CDE ↗
舒必利 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190003338A2025/05/31CDE ↗
尼可地尔 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190003337A2025/06/21CDE ↗
盐酸硫必利 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190003336A2025/06/13CDE ↗
葡醛内酯 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190003334A—CDE ↗
水飞蓟宾 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190003331A2025/06/21CDE ↗
氟他胺 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190003329A2025/05/29CDE ↗
替莫唑胺 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190003328A2025/06/13CDE ↗
替米沙坦 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20190003325A2025/05/29CDE ↗
卡培他滨 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20170000321A2025/06/05CDE ↗
盐酸苯海索 · No verified English nameJiangsu TaslyDiYi Pharmaceutical Co., LtdY20170000242A2023/04/05CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

4 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/20.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Bendamustine Hydrochloride For Injection CYHS2302078Generic2023/08/02Nanjing Li Cheng Pharma Co., Ltd. romanized; Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Bendamustine Hydrochloride For Injection CYHS2302077Generic2023/08/02Nanjing Li Cheng Pharma Co., Ltd. romanized; Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Afatinib Dimaleate Tablets CYHS2200082Generic2022/01/13Jiangsu Kang Bei De Pharma Co., Ltd. romanized; Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗
Afatinib Dimaleate Tablets CYHS2200081Generic2022/01/13Jiangsu Kang Bei De Pharma Co., Ltd. romanized; Jiangsu TaslyDiYi Pharmaceutical Co., LtdCDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/20
Chemical-drug catalogue
Last successful update: 2026/11/20
API registrations
Last successful update: 2026/11/20
NMPA drug delivery notices
Last successful update: 2026/11/20

Loaded notices dated 2026-11-06 to 2026-11-20; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.